[go: up one dir, main page]

TR201007109A2 - Single unit dosage forms. - Google Patents

Single unit dosage forms.

Info

Publication number
TR201007109A2
TR201007109A2 TR2010/07109A TR201007109A TR201007109A2 TR 201007109 A2 TR201007109 A2 TR 201007109A2 TR 2010/07109 A TR2010/07109 A TR 2010/07109A TR 201007109 A TR201007109 A TR 201007109A TR 201007109 A2 TR201007109 A2 TR 201007109A2
Authority
TR
Turkey
Prior art keywords
dosage forms
single unit
unit dosage
donepezil
alzheimer
Prior art date
Application number
TR2010/07109A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07109A priority Critical patent/TR201007109A2/en
Priority to TR2011/08087A priority patent/TR201108087A2/en
Priority to PCT/TR2011/000192 priority patent/WO2012026904A1/en
Publication of TR201007109A2 publication Critical patent/TR201007109A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş donepezil veya farmasötik açıdan uygun herhangi bir türevini ve ginkgo biloba özütü içeren tek birim dozaj formlarma ve bu tarz dozaj formlarının alzheimer tedavisinde kullanımına ilişkindir.The present invention relates to single unit dosage forms comprising donepezil or any pharmaceutically acceptable derivative thereof and ginkgo biloba extract, and the use of such dosage forms in the treatment of Alzheimer's.

TR2010/07109A 2010-08-25 2010-08-25 Single unit dosage forms. TR201007109A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/07109A TR201007109A2 (en) 2010-08-25 2010-08-25 Single unit dosage forms.
TR2011/08087A TR201108087A2 (en) 2010-08-25 2011-08-12 Single unit solid dosage forms.
PCT/TR2011/000192 WO2012026904A1 (en) 2010-08-25 2011-08-19 A single unit dosage form on the basis of a combination comprising donepezil and ginkgo biloba extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07109A TR201007109A2 (en) 2010-08-25 2010-08-25 Single unit dosage forms.

Publications (1)

Publication Number Publication Date
TR201007109A2 true TR201007109A2 (en) 2012-03-21

Family

ID=44947168

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2010/07109A TR201007109A2 (en) 2010-08-25 2010-08-25 Single unit dosage forms.
TR2011/08087A TR201108087A2 (en) 2010-08-25 2011-08-12 Single unit solid dosage forms.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2011/08087A TR201108087A2 (en) 2010-08-25 2011-08-12 Single unit solid dosage forms.

Country Status (2)

Country Link
TR (2) TR201007109A2 (en)
WO (1) WO2012026904A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007774A1 (en) * 2012-07-02 2014-01-09 Mahmut Bilgic Water soluble formulations comprising a piperidine derivative active agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt

Also Published As

Publication number Publication date
WO2012026904A1 (en) 2012-03-01
TR201108087A2 (en) 2012-07-23

Similar Documents

Publication Publication Date Title
BR112015020466A8 (en) cdc7 inhibitors, their uses, and pharmaceutical composition
MY191357A (en) Sustained-release dosage forms of ruxolitinib
UA108198C2 (en) Substituted 2-acetamido-5-aryl-l, 2,4-triazolones and their use
MX2020010535A (en) Methods of treating cancer.
TN2015000076A1 (en) Methods of treating alzheimer's disease and pharmaceutical compositions thereof
UA109650C2 (en) BIS-ARLYZED ARILTRIAZOLONS AND THEIR APPLICATIONS
UA107550C2 (en) ESTRA-1,3,5 (10), 16-TETRAEIN-3-CARBOXAMAMID DERIVATIVES, THE METHODS OF THEIR PREPARATION, THE PHARMACEUTICAL PREPARATIONS THEREOF, AND THEIR USE
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016002580A (en) Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases.
IN2012DN05186A (en)
CL2014003325A1 (en) Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease
CL2012001940A1 (en) Compositions comprising extracts of andrographis paniculata combined with extracts of ginkgo biloba complexed with phospholipids; and its use in the preparation of a medicament for the treatment of Alzheimer's and multiple sclerosis.
CL2014003607A1 (en) Compounds derived from benzodioxol, acetylcholinesterase inhibitors; Preparation method; intermediary compounds; pharmaceutical composition; and use in the prevention or treatment of Alzheimer's disease.
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
TR201007110A2 (en) Combinations with synergistic effects
UA118474C2 (en) (S) -PIRLINDOL AND ITS PHARMACEUTICALLY ACCEPTED SALTS FOR MEDICINAL USE
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
UA116499C2 (en) (R) -PIRLINDOL AND ITS PHARMACEUTICALLY ACCEPTED SALTS FOR MEDICINAL USE
TR201007109A2 (en) Single unit dosage forms.
TR201007111A2 (en) Compositions showing synergistic effects.
TR201100152A2 (en) Effervescent compositions containing amlodipine.
WO2014023869A3 (en) Therapeutic use of cd44 inhibitor agents against human acute lymphoblastic leukaemia (all)
TR200906322A2 (en) Granules with improved solubility and stability properties.
TR201204568A2 (en) Effervescent tablet containing galantamine.
TR201205320A2 (en) Galantamine formulations and production method